Mallet PE and Beninger RJ |
Delta9-tetrahydrocannabinol, but not the endogenous cannabinoid receptor ligand anandamide, produces conditioned place avoidance. |
1998 |
Life Sci. |
pmid:9651110
|
De Petrocellis L et al. |
The endogenous cannabinoid anandamide inhibits human breast cancer cell proliferation. |
1998 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:9653194
|
Edgemond WS et al. |
Human platelets and polymorphonuclear leukocytes synthesize oxygenated derivatives of arachidonylethanolamide (anandamide): their affinities for cannabinoid receptors and pathways of inactivation. |
1998 |
Mol. Pharmacol. |
pmid:9658204
|
Patel NA et al. |
Arachidonylethanolamide (AEA) activation of FOS proto-oncogene protein immunoreactivity in the rat brain. |
1998 |
Brain Res. |
pmid:9666136
|
van Zadelhoff G et al. |
With anandamide as substrate plant 5-lipoxygenases behave like 11-lipoxygenases. |
1998 |
Biochem. Biophys. Res. Commun. |
pmid:9675081
|
Qin C et al. |
Determination of anandamide amidase activity using ultraviolet-active amine derivatives and reverse-phase high-performance liquid chromatography. |
1998 |
Anal. Biochem. |
pmid:9683506
|
Calignano A et al. |
Control of pain initiation by endogenous cannabinoids. |
1998 |
Nature |
pmid:9685157
|
Stefano GB et al. |
Macrophage behavior associated with acute and chronic exposure to HIV GP120, morphine and anandamide: endothelial implications. |
1998 |
Int. J. Cardiol. |
pmid:9687087
|
Bisogno T et al. |
Biosynthesis and degradation of bioactive fatty acid amides in human breast cancer and rat pheochromocytoma cells--implications for cell proliferation and differentiation. |
1998 |
Eur. J. Biochem. |
pmid:9688276
|
Jaggar SI et al. |
The anti-hyperalgesic actions of the cannabinoid anandamide and the putative CB2 receptor agonist palmitoylethanolamide in visceral and somatic inflammatory pain. |
1998 |
Pain |
pmid:9696473
|